Dapagliflozin Alleviates Non-Alcoholic Fatty Liver Disease in Mice by Inhibiting Ferroptosis Through Activating the SIRT1/Nrf2 Pathway

  • Tohoku J Exp Med. 2026 May 14. doi: 10.1620/tjem.2026.J037.
Min Liu  1 ,  BiYing Meng  1 ,  Jing Dong  1 ,  Lin Xiang  1
Affiliations
  • 1. Department of Endocrinology, General Hospital of the Central Theater Command.
PMID: 42128820 DOI: 10.1620/tjem.2026.J037
Products